Hyaluronic Acid: An Effective Alternative Treatment of Interstitial Cystitis, Recurrent Urinary Tract Infections, and Hemorrhagic Cystitis?

European Urology

Volumn 51, Issue 6, 2007, Pages 1534-1541

  Iavazzo, Christos ^a   Athanasiou, Stavros ^a,b   Pitsouni, Eleni ^a   Falagas, Matthew E ^a,c  

^a ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cystitis; Glycosaminoglycan replacement treatment; Hyaluronate; Intravesical administration

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; BCG VACCINE; BOTULINUM TOXIN; DEXTRO ARGINYL DEXTRO NORLEUCYL DEXTRO NORLEUCYL DEXTRO NORLEUCYL DEXTRO ARGINYL DEXTRO NORLEUCYL DEXTRO NORLEUCYL DEXTRO NORLEUCYLGLYCYL DEXTRO TYROSINAMIDE; DIMETHYL SULFOXIDE; ESTROGEN; HEPARIN; HYALURONIC ACID; PENTOSAN POLYSULFATE; RESINIFERATOXIN; TRICYCLIC ANTIDEPRESSANT AGENT;

BACTERIAL CYSTITIS; BLADDER IRRITATION; CATHETERIZATION; CLINICAL STUDY; COST; CYSTITIS; DRUG EFFICACY; ESTROGEN THERAPY; HEMORRHAGIC CYSTITIS; HUMAN; INTERSTITIAL CYSTITIS; MEDLINE; PRIORITY JOURNAL; RECURRENT INFECTION; REVIEW; UNITED KINGDOM; URINARY TRACT INFECTION;

ADJUVANTS, IMMUNOLOGIC; CYSTITIS; CYSTITIS, INTERSTITIAL; FEMALE; HEMORRHAGE; HUMANS; HYALURONIC ACID; RECURRENCE; URINARY TRACT INFECTIONS;

EID: 34247332338     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2007.03.020     Document Type: Review

References (39)

1. Available at: http://wikipedia.org/wiki/Cochrane_Collaboration.
2. Miodosky M., Abdul-Hai A., Tsirigotis P., et al. Treatment of post-hematopoietic stem cell transplantation hemorrhagic cystitis with intravesicular sodium hyaluronate. Bone Marrow Transplant 38 (2006) 507-511
3. Morales A., Emerson L., and Nickel J.C. Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. Urology 49 5A suppl (1997) 111-113
4. Sato H., Takahashi T., and Ide H. Antioxidant activity of synovial fluid, hyaluronic acid and two sub-components of hyaluronic acid. Synovial fluid scavenging effect is enhanced in rheumatoid arthritis patients. Arch Rheum 31 (1988) 63-67
5. Goldberg R.L., and Toole B.P. Hyaluronate inhibition of cell proliferation. Arth Rheum 30 (1987) 769-773
6. Abatangelo G., Martelli M., and Vecchia P. Healing of hyaluronic acid-enriched wounds: histological observations. J Surg Res 35 (1983) 410-414
7. Hadler N.M., and Napier M.A. Structure of hyaluronic acid in synovial fluid and its influence on the movement of solutes. Sem Arth Rheum 7 (1977) 141-146
8. Hurst R.E., Rhodes S.W., Adamson P.B., et al. Functional and structural characteristics of the glycosaminoglycans of the bladder luminal surface. J Urol 138 (1987) 433-437
9. Parsons C.L. The therapeutic role of sulphated polysaccharides in urinary bladder. Urol Clin North Am 21 (1994) 93-100
10. Goldberg R.L., and Tole B.P. Hyaluronate inhibition of cell proliferation. Arthritis Rheum 30 (1987) 769-778
11. Morales A., Emerson L., Nickel J.C., et al. Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. J Urol 156 (1996) 45-48
12. Constantinides C., Manousakas T., Nikolopoulos P., et al. Prevention of recurrent bacterial cystitis by intravesical administration of hyaluronic acid: a pilot study. BJU Int 93 (2004) 1262-1266
13. Gidwani S., and Fairbank A. The orthopaedic approach to managing osteoarthritis of the knee. BMJ 329 (2004) 1220-1224
14. Kunz L.I.Z., Van Rensen E.L.J., and Sterk P.J. Inhaled hyaluronic acid against exercise-induced bronchocostriction in asthma. Pulm Pharmacol Ther 19 (2006) 286-291
15. Maltese A., Borzacchiello A., Mayol L., et al. Novel polysaccharides-based viscoelastic formulation for ophthalmic surgery: rheological characterization. Biomaterials 27 (2006) 5134-5142
16. Hertegard S., Hallen L., Laurent C., et al. Cross-linked hyaluronan used as augmentation substance for treatment of glottal insufficiency: safety aspects and vocal fold function. Laryngoscope 112 (2002) 2211-2219
17. Monheit G.D., and Coleman K.M. Hyaluronic acid fillers. Dermatol Ther 19 (2006) 141-150
18. Puri P., Pirker M., Mohanan N., et al. Subureteral dextranomer/hyaluronic acid injection as first line treatment in the management of high grade vesicoureteral reflux. J Urol 176 (2006) 1856-1859
19. Daha L.K., Riedl C.R., Lazar D., et al. Do cystometric findings predict the results of intravesical hyaluronic acid in women with interstitial cystitis?. Eur Urol 47 (2005) 393-397
20. Kallestrup E.B., Jorgensen S.S., Nordling J., et al. Treatment of interstitial cystitis with Cystistat: a hyaluronic acid product. Scand J Urol Nephrol 39 (2005) 143-147
21. Temml C., Wehrberger C., Riedl C., et al. Prevalence and correlates for interstitial cystitis symptoms in women participating in a health screening project. Eur Urol 51 (2007) 803-809
22. Gupta S.K., Pidcock L., and Parr N.J. The potassium sensitivity test: a predictor of treatment response in interstitial cystitis. BJU Int 96 (2005) 1063-1066
23. Parsons C.L., Stein P.C., Bidair M., et al. Abnormal sensitivity to intravesical potassium in interstitial cystitis and radiation cystitis. Neurourol Urodyn 13 (1994) 515-520
24. Moldwin R.M., and Sant G.R. Interstitial cystitis: a pathophysiology and treatment update. Clin Obstet Gynecol 45 (2002) 259-272
25. Morales A., Emerson L., and Nickel J.C. Treatment of refractory interstitial cystitis. Int Urogynecol J Pelvic Floor Dysfunct 7 (1996) 215-220
26. Nordling J., Jorgensen S., and Kallestrup E. Cystistat for the treatment of interstitial cystitis: a 3-year follow-up study. Urology 57 6 suppl 1 (2001) 123
27. Lokeshwar V.B., Selzer M.G., Unwala D.J., et al. Uronate peaks and urinary hyaluronic acid levels correlate with interstitial cystitis severity. J Urol 176 (2006) 1001-1007
28. Ruggieri M.R., Chelsky M.J., Rosen S.I., et al. Current findings and future research avenues in the study of interstitial cystitis. Urol Clin North Am 21 (1994) 163-176
29. Parsons C. Current strategies for managing interstitial cystitis. Expert Opin Pharmacother 5 (2004) 287-293
30. Parsons C.L., Housley T., Schmidt J.D., et al. Treatment of interstitial cystitis with intravesical heparin. Br J Urol 73 (1994) 504-507
31. Parsons C.L. Prevention of urinary tract infection by the exogenous glycosaminoglycan sodium pentosanpolysulfate. J Urol 127 (1982) 167-169
32. Toft B.R., and Nordling J. Recent developments of intravesical therapy of painful bladder syndrome/interstitial cystitis: a review. Curr Opin Urol 16 (2006) 268-272
33. Falagas M.E., and Gorbach S.L. Urinary tract infections: practice guidelines. Infect Dis Clin Practice 4 (1995) 241-257
34. Sobota A.E. Inhibition of bacterial adherence by cranberry juice; potential use for the treatment of urinary tract infections. J Urol 131 (1984) 1013-1016
35. Falagas M.E., Betsi G.I., Tokas T., et al. Probiotics for prevention of recurrent urinary tract infections in women: a review of the evidence from microbiological and clinical studies. Drugs 66 (2006) 1253-1261
36. Riedl C.R., Daha L.K., Pfluger H., et al. Intravesical hyaluronic acid for the treatment of interstitial cystitis. J Urol 169 Suppl A (2003) 265
37. Gupta SK. Re: Daha LK, Riedl CR, Lazar D, Hohlbrugger G, Pflüger H. Do cystometric findings predict the results of intravesical hyaluronic acid in women with interstitial cystitis? Eur Urol 2005;47:393-7. Eur Urol 2005;48:534.
38. Leppilahti M., Hellstrom P., and Tammela T.L. Effect of diagnostic hydrodistension and four intravesical hyaluronic acid instillations on bladder ICAM-1 intensity and association of ICAM-1 intensity with clinical response in patients with interstitial cystitis. Urology 60 (2002) 46-51
39. Porru D., Tinelli C., Gerardini M., et al. Results of treatment of refractory interstitial cystitis with intravesical hyaluronic acid. Urol Int 59 (1997) 26-29